← Back to Search

MRI Sequence

MR Fingerprinting for Neurological Disorders

N/A
Waitlist Available
Led By Yueh Z Lee, MD, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
The study will include English-speaking patients that are already scheduled to undergo a clinical neurological MRI for diagnostic purposes.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up immediately following mri completion, within approximately 5 minutes
Awards & highlights

Study Summary

MR Fingerprinting: A Novel Sequence Applied to Neuroimaging

Eligible Conditions
  • Neurological Disorders

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~immediately following mri completion, within approximately 5 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and immediately following mri completion, within approximately 5 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent of Participants With Visible Region of Interest (Imaging Visibility)

Trial Design

1Treatment groups
Experimental Treatment
Group I: All ParticipantsExperimental Treatment1 Intervention
All participants will receive the investigational MR Fingerprinting sequence.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MR Fingerprinting
2019
N/A
~70

Find a Location

Who is running the clinical trial?

University of North Carolina, Chapel HillLead Sponsor
1,504 Previous Clinical Trials
4,187,648 Total Patients Enrolled
Yueh Z Lee, MD, PhDPrincipal InvestigatorUniversity of North Carolina, Chapel Hill

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~2 spots leftby Apr 2025